have described the identification of novel candidate genes for late onset PD
Tierstudien deuten auf anxiolytische und antidepressive Wirkungen hin, mglicherweise vermittelt durch die Interaktion mit den dopaminergen und serotonergen Systemen
The pharmacological profile is no longer driven by a single dominant interaction, but by coordinated, residence-time-controlled modulation of SGLT2, attenuated SGLT1 engagement, and softened yet functionally relevant DPP-4 inhibition
Common adverse effects in trials include nausea, vomiting, diarrhoea, and constipation
Management: o Use cautiously and under medical supervision
5.4 Hypoglycemia SPL UNCLASSIFIED SECTION WEGOVY lowers blood glucose and can cause hypoglycemia